Comment from US Compounding, Inc.

Summary: US Compounding, Inc., a human drug compounding outsourcing facility, argues that succinylcholine chloride should be added to the FDA's 503B bulk drug substances list. They contend that there is a significant clinical need for a preservative-free formulation to treat patients with sensitivities to parabens found in commercially available products.